Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Antengene (6996 HK)
Watchlist
44
Analysis
Health Care
•
China
Antengene Corporation Limited operates as a specialty pharmaceutical company. The Company produces innovative drugs, selinexor, eltanexor, verdinexor, and other products. Antengene provides its services throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
16 May 2021 08:50
China Healthcare Weekly (May.14)
This article analyzed new guidance on retail pharmacies in the medical insurance, information collection of the 5th national VBP, China's sleep...
Xinyao (Criss) Wang
Follow
223 Views
Share
bearish
•
Thematic (Sector/Industry)
•
09 May 2021 09:16
China Healthcare Weekly (May.7)
The article analyzed the potential impact on Biden’s proposal to waive IP protection on COVID-19 shots,market size of COVID-19 vaccine,new...
Xinyao (Criss) Wang
Follow
230 Views
Share
bearish
•
Thematic (Sector/Industry)
•
18 Apr 2021 09:09
China Healthcare Weekly (Apr.16)
The article analyzed the investment opportunities in China medical device industry under VBP, future trend of cell and gene therapy, market...
Xinyao (Criss) Wang
Follow
204 Views
Share
bearish
•
Thematic (Sector/Industry)
•
11 Apr 2021 08:27
China Healthcare Weekly (Apr.9)
The article analyzed intensive procurement of high-value orthopedic consumables,new policy about long-term prescription management,the patch-type...
Xinyao (Criss) Wang
Follow
233 Views
Share
bearish
•
Thematic (Sector/Industry)
•
01 Mar 2021 09:25
China Healthcare Weekly (Feb.26)
This article analyzed the VBP policy on Chinese patent medicines, the growth potential in the chemiluminescence and intensive procurement of IVD...
Xinyao (Criss) Wang
Follow
226 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x